Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COGNITION: Comprehensive Assessment of Clinical Features, Genomics and Further Molecular Markers to Identify Patients With Early Breast Cancer for Enrolment on Marker Driven Trials (Molecular Diagnostic Platform)

NCT05906407 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT05906407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05906407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COGNITION: Comprehensive Assessment of Clinical Features, Genomics and Further Molecular Markers to Identify Patients With Early Breast Cancer for Enrolment on Marker Driven Trials (Molecular Diagnostic Platform)
Lead sponsor
German Cancer Research Center
Phase
Observational
Overall status
Recruiting
Start date
April 19, 2019
Completion date
December 31, 2028
Enrollment
2,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer, neoadjuvant therapy